𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Heparin-binding epidermal growth factor-like growth factor as a novel targeting molecule for cancer therapy

✍ Scribed by Shingo Miyamoto; Hiroshi Yagi; Fusanori Yotsumoto; Tatsuhiko Kawarabayashi; Eisuke Mekada


Book ID
108583626
Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
335 KB
Volume
97
Category
Article
ISSN
1347-9032

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Heparin-binding epidermal growth factor-
✍ Christopher Kramer; Kai Klasmeyer; Hans Bojar; Wolfgang A. Schulz; Rolf Ackerman 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 313 KB 👁 1 views

## Abstract ## BACKGROUND. Cleavage of membrane‐anchored heparin‐binding epidermal growth factor‐like growth factor (proHB‐EGF) yields a soluble HB‐EGF isoform (sHB‐EGF), which is an activating epidermal growth factor receptor (EGFR) ligand and a C‐terminal fragment HB‐EGF‐C acting directly in the

Role of heparin-binding epidermal growth
✍ Shinichi Kiso; Sumio Kawata; Shinji Tamura; Shigeki Higashiyama; Nobuyuki Ito; H 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 887 KB

Several growth factors including hepatocyte growth factor (HGF) have been implicated in the regulation of liver regeneration. Recently, we reported that heparin-binding epidermal growth factor (EGF)-like growth factor (HB-EGF) has hepatotrophic effects in vitro. We investigated the role of HB-EGF as